J 2022

Prenylated phenolics from Morus alba against MRSA infections as a strategy for wound healing

ŠKOVRANOVÁ, Gabriela, Marie ČULENOVÁ, Jakub TREML, Lucia DZURICKA, Ivana MAROVA et. al.

Basic information

Original name

Prenylated phenolics from Morus alba against MRSA infections as a strategy for wound healing

Authors

ŠKOVRANOVÁ, Gabriela (703 Slovakia, guarantor, belonging to the institution), Marie ČULENOVÁ (203 Czech Republic, belonging to the institution), Jakub TREML (203 Czech Republic, belonging to the institution), Lucia DZURICKA, Ivana MAROVA and Alice SYCHROVÁ (203 Czech Republic, belonging to the institution)

Edition

Frontiers in Pharmacology, Lausanne, Frontiers Media SA, 2022, 1663-9812

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.600

RIV identification code

RIV/00216224:14160/22:00128069

Organization unit

Faculty of Pharmacy

UT WoS

000898590100001

Keywords in English

antibacterial activity; antimicrobial resistance; kuwanon C; MRSA; mulberry; prenylated phenolics; synergy; wound healing

Tags

Tags

International impact, Reviewed
Změněno: 18/1/2023 09:18, JUDr. Sabina Krejčiříková

Abstract

V originále

Antimicrobial resistance is a public health threat and the increasing number of multidrug-resistant bacteria is a major concern worldwide. Common antibiotics are becoming ineffective for skin infections and wounds, making the search for new therapeutic options increasingly urgent. The present study aimed to investigate the antibacterial potential of prenylated phenolics in wound healing. Phenolic compounds isolated from the root bark of Morus alba L. were investigated for their antistaphylococcal potential both alone and in combination with commonly used antibiotics. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) were determined by microdilution and agar method. Synergy was investigated using the checkerboard titration technique. Membrane-disrupting activity and efflux pump inhibition were evaluated to describe the potentiating effect. Prenylated phenolics inhibited bacterial growth of methicillin-resistant Staphylococcus aureus (MRSA) at lower concentrations (MIC 2-8 mu g/ml) than commonly used antibiotics. The combination of active phenolics with kanamycin, oxacillin, and ciprofloxacin resulted in a decrease in the MIC of the antimicrobial agent. Kuwanon C, E, T, morusin, and albafuran C showed synergy (FICi 0.375-0.5) with oxacillin and/or kanamycin. Prenylated phenolics disrupted membrane permeability statistically significantly (from 28 +/- 16.48% up to 73 +/- 2.83%), and membrane disruption contributes to the complex antibacterial activity against MRSA. In addition, kuwanon C could be considered an efflux pump inhibitor. Despite the antibacterial effect on MRSA and the multiple biological activities, the prenylated phenolics at microbially significant concentrations have a minor effect on human keratinocyte (HaCaT) viability. In conclusion, prenylated phenolics in combination with commonly used antibiotics are promising candidates for the treatment of MRSA infections and wound healing, although further studies are needed.

Links

MUNI/A/1279/2021, interní kód MU
Name: Mechanizmus antimikrobiálneho účinku fenolických látok voči Gram-pozitívnym baktériám.
Investor: Masaryk University
MUNI/C/0036/2021, interní kód MU
Name: Testování synergické aktivity obsahových látek Paulownia tomentosa s konvenčními antibiotiky
Investor: Masaryk University, Excellent diploma thesis